English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907298      Online Users : 908
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/9125


    Title: Role of mitochondrial dysfunction and dysregulation of Ca2+ homeostasis in insulin insensitivity of mammalian cells
    Authors: Wang, CH;Tsai, TF;Wei, YH
    Contributors: Institute of Molecular and Genomic Medicine
    Abstract: Mitochondria and endoplasmic reticulum (ER) play an important role in the maintenance of intracellular Ca2+ homeostasis, and their defects may be etiological factors contributing to insulin resistance and type 2 diabetes (T2D). Recent studies indicate that alterations of Ca2+ levels and Ca2+ -dependent signaling pathways can impede the insulin signaling cascade, resulting in insulin resistance of beta cells and insulin-responsive cells. Mitochondria-associated ER membranes (MAMs) are essential for efficient communication between the ER and mitochondria. Thus, abnormalities in the structure and function of MAMs in affected tissue cells in T2D are an important area of study. Recently, we demonstrated that a deficiency of Cisd2, an iron-sulfur protein localized on MAMs, could lead to mitochondrial dysfunction and disturbance of intracellular Ca2+ homeostasis. Moreover, we first elucidated that defects in the function of MAMs in Ca2+ uptake resulted in insulin insensitivity of adipocytes, which plays an important role in the pathogenesis of diabetes in Cisd2 knockout mice. On the basis of these observations, we suggest improving the bioenergetic function of mitochondria and the function of MAMs in maintaining Ca2+ homeostasis as a novel strategy for the development of new therapeutics aimed at preventing and treating insulin resistance and T2D.
    Date: 2015-09
    Relation: Annals of the New York Academy of Sciences. 2015 Sep;1350:66-76.
    Link to: http://dx.doi.org/10.1111/nyas.12838
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0077-8923&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000361375900008
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84937862938
    Appears in Collections:[其他] 期刊論文

    Files in This Item:

    File SizeFormat
    PUB26214798.pdf358KbAdobe PDF393View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback